3651 results for «394»
3651 results
A word from our sponsor
15 May 2023 – From PCR Innovators Day 2023
How will "Big Data" and artificial intelligence change the practice in Interventional Cardiology?
15 May 2023 – From PCR Innovators Day 2023
Interventions on Pulmonary Embolism: The Next Big Thing?
15 May 2023 – From PCR Innovators Day 2023
Feedback from Innovator's Exchange Hub
15 May 2023 – From PCR Innovators Day 2023
STEMI Vignettes - The global classroom
18 May 2023 – From EuroPCR 2023
Through these cases, explore global STEMI management and understand various geographic challenges and complication management approaches.
PCR's Got Talent - Round 1 - Session 2
16 May 2023 – From EuroPCR 2023
Did you participate in this session and want to enhance your memory? Take a look at the slides shared by the presenters and revisit the key points worth remembering.
Innovations in Heart Failure: Pumps, Remodeling and Monitoring
15 May 2023 – From PCR Innovators Day 2023
What else will become the "Next Big Thing" in Coronary Artery Disease, Peripheral Vascular, treatment of Hypertension or Cardiovascular Imaging for the Interventional Cardiologist?
15 May 2023 – From PCR Innovators Day 2023
EuroPCR 2026 – Long-term mortality following revascularisation for left main disease
20 May 2026
Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is a meta-analysis of long-term data from 4 randomised trials investigating...
Controlled ring expansion during aortic valve-in-valve: a proof-of-concept CT-scan analysis
24 Jun 2024
Analyze this EIJ image to see how surgical aortic bioprostheses with expandable ring technology can significantly enhance future ViV procedures.
Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial
20 Sep 2022
Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.
It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...
Author
